BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harfe BD. MicroRNAs in vertebrate development. Curr Opin Genet Dev. 2005;15:410-415. [PMID: 15979303 DOI: 10.1016/j.gde.2005.06.012] [Cited by in Crossref: 251] [Cited by in F6Publishing: 222] [Article Influence: 15.7] [Reference Citation Analysis]
Number Citing Articles
1 Gao Z, Wang YT, Wu QW, Ni JC, Zheng CH. Graph regularized L2,1-nonnegative matrix factorization for miRNA-disease association prediction. BMC Bioinformatics 2020;21:61. [PMID: 32070280 DOI: 10.1186/s12859-020-3409-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
2 Jiang L, Meng W, Zeng J, Hu H, Lu L. MiR-34c oligonucleotide enhances chemosensitivity of Ishikawa cell to cisplatin by inducing apoptosis. Cell Biol Int 2013;37:577-83. [PMID: 23412924 DOI: 10.1002/cbin.10074] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
3 Ohgawara T, Kubota S, Kawaki H, Kondo S, Eguchi T, Kurio N, Aoyama E, Sasaki A, Takigawa M. Regulation of chondrocytic phenotype by micro RNA 18a: involvement of Ccn2/Ctgf as a major target gene. FEBS Lett. 2009;583:1006-1010. [PMID: 19233176 DOI: 10.1016/j.febslet.2009.02.025] [Cited by in Crossref: 68] [Cited by in F6Publishing: 58] [Article Influence: 5.7] [Reference Citation Analysis]
4 Han Li C, Chen Y. Small and Long Non-Coding RNAs: Novel Targets in Perspective Cancer Therapy. Curr Genomics 2015;16:319-26. [PMID: 27047252 DOI: 10.2174/1389202916666150707155851] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 11.4] [Reference Citation Analysis]
5 Govindaraju A, Uzun A, Robertson L, Atli MO, Kaya A, Topper E, Crate EA, Padbury J, Perkins A, Memili E. Dynamics of microRNAs in bull spermatozoa. Reprod Biol Endocrinol 2012;10:82. [PMID: 22978562 DOI: 10.1186/1477-7827-10-82] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 5.8] [Reference Citation Analysis]
6 Oura K, Fujita K, Morishita A, Iwama H, Nakahara M, Tadokoro T, Sakamoto T, Nomura T, Yoneyama H, Mimura S, Tani J, Kobara H, Okano K, Suzuki Y, Masaki T. Serum microRNA-125a-5p as a potential biomarker of HCV-associated hepatocellular carcinoma. Oncol Lett 2019;18:882-90. [PMID: 31289566 DOI: 10.3892/ol.2019.10385] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
7 Liu FJ, Wen T, Liu L. MicroRNAs as a novel cellular senescence regulator. Ageing Res Rev 2012;11:41-50. [PMID: 21689787 DOI: 10.1016/j.arr.2011.06.001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
8 Gillis AJ, Stoop HJ, Hersmus R, Oosterhuis JW, Sun Y, Chen C, Guenther S, Sherlock J, Veltman I, Baeten J, van der Spek PJ, de Alarcon P, Looijenga LH. High-throughput microRNAome analysis in human germ cell tumours. J Pathol 2007;213:319-28. [PMID: 17893849 DOI: 10.1002/path.2230] [Cited by in Crossref: 153] [Cited by in F6Publishing: 140] [Article Influence: 10.9] [Reference Citation Analysis]
9 Yan L, Yan Y, Pei L, Wei W, Zhao J. A G-quadruplex DNA-based, label-free and ultrasensitive strategy for microRNA detection. Sci Rep 2014;4:7400. [PMID: 25492390 DOI: 10.1038/srep07400] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
10 Nebbioso A, Carafa V, Benedetti R, Altucci L. Trials with 'epigenetic' drugs: an update. Mol Oncol 2012;6:657-82. [PMID: 23103179 DOI: 10.1016/j.molonc.2012.09.004] [Cited by in Crossref: 183] [Cited by in F6Publishing: 148] [Article Influence: 20.3] [Reference Citation Analysis]
11 Rameshwar P, Moore CA, Shah NN, Smith CP. An Update on the Therapeutic Potential of Stem Cells. Methods Mol Biol 2018;1842:3-27. [PMID: 30196398 DOI: 10.1007/978-1-4939-8697-2_1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Mashimo Y, Mie M, Suzuki S, Kobatake E. Detection of small RNA molecules by a combination of branched rolling circle amplification and bioluminescent pyrophosphate assay. Anal Bioanal Chem 2011;401:221-7. [DOI: 10.1007/s00216-011-5083-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
13 Calin GA, Pekarsky Y, Croce CM. The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. Best Pract Res Clin Haematol 2007;20:425-37. [PMID: 17707831 DOI: 10.1016/j.beha.2007.02.003] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 5.2] [Reference Citation Analysis]
14 Yoong LF, Wan G, Too HP. Glial cell-line derived neurotrophic factor and neurturin regulate the expressions of distinct miRNA precursors through the activation of GFRalpha2. J Neurochem 2006;98:1149-58. [PMID: 16895582 DOI: 10.1111/j.1471-4159.2006.03959.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
15 Li L, Gao Z, Wang YT, Zhang MW, Ni JC, Zheng CH, Su Y. SCMFMDA: Predicting microRNA-disease associations based on similarity constrained matrix factorization. PLoS Comput Biol 2021;17:e1009165. [PMID: 34252084 DOI: 10.1371/journal.pcbi.1009165] [Reference Citation Analysis]
16 Waldman SA, Terzic A. A study of microRNAs in silico and in vivo: diagnostic and therapeutic applications in cancer. FEBS J 2009;276:2157-64. [PMID: 19250312 DOI: 10.1111/j.1742-4658.2009.06934.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
17 Uhl E, Krimer P, Schliekelman P, Tompkins SM, Suter S. Identification of altered MicroRNA expression in canine lymphoid cell lines and cases of B- and T-Cell lymphomas. Genes Chromosomes Cancer 2011;50:950-67. [PMID: 21910161 DOI: 10.1002/gcc.20917] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
18 Riazalhosseini B, Mohamed R, Apalasamy YD, Langmia IM, Mohamed Z. Circulating microRNA as a marker for predicting liver disease progression in patients with chronic hepatitis B. Rev Soc Bras Med Trop 2017;50:161-6. [PMID: 28562750 DOI: 10.1590/0037-8682-0416-2016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
19 Zhao J, Fu Y, Wu J, Li J, Huang G, Qin L. The Diverse Mechanisms of miRNAs and lncRNAs in the Maintenance of Liver Cancer Stem Cells. Biomed Res Int 2018;2018:8686027. [PMID: 29888282 DOI: 10.1155/2018/8686027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
20 Conte I, Banfi S, Bovolenta P. Non-coding RNAs in the development of sensory organs and related diseases. Cell Mol Life Sci 2013;70:4141-55. [PMID: 23588489 DOI: 10.1007/s00018-013-1335-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
21 Geisler A, Jungmann A, Kurreck J, Poller W, Katus HA, Vetter R, Fechner H, Müller OJ. microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors. Gene Ther. 2011;18:199-209. [PMID: 21048795 DOI: 10.1038/gt.2010.141] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 7.3] [Reference Citation Analysis]
22 Pan QW, Henry SD, Scholte BJ, Tilanus HW, Janssen HL, van der Laan LJ. New therapeutic opportunities for hepatitis C based on small RNA. World J Gastroenterol 2007;13:4431-6. [PMID: 17724797 DOI: 10.3748/wjg.v13.i33.4431] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
23 Goswami RS, Atenafu EG, Xuan Y, Waldron L, Reis PP, Sun T, Datti A, Xu W, Kuruvilla J, Good DJ, Lai R, Church AJ, Lam WS, Baetz T, Lebrun DP, Sehn LH, Farinha P, Jurisica I, Bailey DJ, Gascoyne RD, Crump M, Kamel-Reid S. MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma. J Clin Oncol 2013;31:2903-11. [PMID: 23835716 DOI: 10.1200/JCO.2012.45.3050] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
24 Kanoria S, Rennie W, Liu C, Carmack CS, Lu J, Ding Y. STarMir Tools for Prediction of microRNA Binding Sites. Methods Mol Biol 2016;1490:73-82. [PMID: 27665594 DOI: 10.1007/978-1-4939-6433-8_6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
25 Song Y, Zhao F, Wang Z, Liu Z, Chiang Y, Xu Y, Gao P, Xu H. Inverse association between miR-194 expression and tumor invasion in gastric cancer. Ann Surg Oncol 2012;19 Suppl 3:S509-17. [PMID: 21845495 DOI: 10.1245/s10434-011-1999-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
26 Giglio S, Cirombella R, Amodeo R, Portaro L, Lavra L, Vecchione A. MicroRNA miR-24 promotes cell proliferation by targeting the CDKs inhibitors p27Kip1 and p16INK4a. J Cell Physiol. 2013;228:2015-2023. [PMID: 23553486 DOI: 10.1002/jcp.24368] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
27 Noguchi S, Kumazaki M, Yasui Y, Mori T, Yamada N, Akao Y. MicroRNA-203 regulates melanosome transport and tyrosinase expression in melanoma cells by targeting kinesin superfamily protein 5b. J Invest Dermatol 2014;134:461-9. [PMID: 23884313 DOI: 10.1038/jid.2013.310] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
28 Bergamaschi A, Katzenellenbogen BS. Tamoxifen downregulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance. Oncogene. 2012;31:39-47. [PMID: 21666713 DOI: 10.1038/onc.2011.223] [Cited by in Crossref: 133] [Cited by in F6Publishing: 123] [Article Influence: 13.3] [Reference Citation Analysis]
29 Biscontin A, Casara S, Cagnin S, Tombolan L, Rosolen A, Lanfranchi G, De Pittà C. New miRNA labeling method for bead-based quantification. BMC Mol Biol 2010;11:44. [PMID: 20553585 DOI: 10.1186/1471-2199-11-44] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
30 Looijenga LH, Gillis AJ, Stoop H, Hersmus R, Oosterhuis JW. Relevance of microRNAs in normal and malignant development, including human testicular germ cell tumours. Int J Androl 2007;30:304-14; discussion 314-5. [PMID: 17573854 DOI: 10.1111/j.1365-2605.2007.00765.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
31 Huang PC, Chen CY, Yang FY, Au LC. A multisampling reporter system for monitoring microRNA activity in the same population of cells. J Biomed Biotechnol 2009;2009:104716. [PMID: 20168979 DOI: 10.1155/2009/104716] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
32 Jay C, Nemunaitis J, Chen P, Fulgham P, Tong AW. miRNA profiling for diagnosis and prognosis of human cancer. DNA Cell Biol. 2007;26:293-300. [PMID: 17504025 DOI: 10.1089/dna.2006.0554] [Cited by in Crossref: 155] [Cited by in F6Publishing: 133] [Article Influence: 11.1] [Reference Citation Analysis]
33 Calin GA, Croce CM. Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications. J Clin Invest 2007;117:2059-66. [PMID: 17671640 DOI: 10.1172/JCI32577] [Cited by in Crossref: 120] [Cited by in F6Publishing: 54] [Article Influence: 8.6] [Reference Citation Analysis]
34 Rennie W, Kanoria S, Liu C, Carmack CS, Lu J, Ding Y. Sfold Tools for MicroRNA Target Prediction. Methods Mol Biol 2019;1970:31-42. [PMID: 30963486 DOI: 10.1007/978-1-4939-9207-2_3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
35 Lee H, Lee S, Bae H, Kang HS, Kim SJ. Genome-wide identification of target genes for miR-204 and miR-211 identifies their proliferation stimulatory role in breast cancer cells. Sci Rep 2016;6:25287. [PMID: 27121770 DOI: 10.1038/srep25287] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
36 Kong AP, Xiao K, Choi KC, Wang G, Chan MH, Ho CS, Chan I, Wong CK, Chan JC, Szeto CC. Associations between microRNA (miR-21, 126, 155 and 221), albuminuria and heavy metals in Hong Kong Chinese adolescents. Clin Chim Acta 2012;413:1053-7. [PMID: 22405870 DOI: 10.1016/j.cca.2012.02.014] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
37 Galun D, Srdic-Rajic T, Bogdanovic A, Loncar Z, Zuvela M. Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies. J Hepatocell Carcinoma 2017;4:93-103. [PMID: 28744453 DOI: 10.2147/JHC.S106529] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
38 Tu K, Zheng X, Dou C, Li C, Yang W, Yao Y, Liu Q. MicroRNA-130b promotes cell aggressiveness by inhibiting peroxisome proliferator-activated receptor gamma in human hepatocellular carcinoma. Int J Mol Sci 2014;15:20486-99. [PMID: 25387077 DOI: 10.3390/ijms151120486] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 7.0] [Reference Citation Analysis]
39 Fabbri M, Garzon R, Andreeff M, Kantarjian HM, Garcia-manero G, Calin GA. MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications. Leukemia 2008;22:1095-105. [DOI: 10.1038/leu.2008.30] [Cited by in Crossref: 107] [Cited by in F6Publishing: 103] [Article Influence: 8.2] [Reference Citation Analysis]
40 Chu H, Wang M, Shi D, Ma L, Zhang Z, Tong N, Huo X, Wang W, Luo D, Gao Y, Zhang Z. Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case-control studies. PLoS One 2011;6:e18108. [PMID: 21483822 DOI: 10.1371/journal.pone.0018108] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
41 Kim GH, Samant SA, Earley JU, Svensson EC. Translational control of FOG-2 expression in cardiomyocytes by microRNA-130a. PLoS One 2009;4:e6161. [PMID: 19582148 DOI: 10.1371/journal.pone.0006161] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
42 Liu X, Liu X, Wu Y, Wu Q, Wang Q, Yang Z, Li L. MicroRNAs in biofluids are novel tools for bladder cancer screening. Oncotarget 2017;8:32370-9. [PMID: 28423688 DOI: 10.18632/oncotarget.16026] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
43 Guo C, Cui H, Ni S, Yan Y, Qin Q. Comprehensive identification and profiling of host miRNAs in response to Singapore grouper iridovirus (SGIV) infection in grouper (Epinephelus coioides). Developmental & Comparative Immunology 2015;52:226-35. [DOI: 10.1016/j.dci.2015.05.014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
44 Qin J, Ke J, Xu J, Wang F, Zhou Y, Jiang Y, Wang Z. Downregulation of microRNA-132 by DNA hypermethylation is associated with cell invasion in colorectal cancer. Onco Targets Ther. 2015;8:3639-3648. [PMID: 26675712 DOI: 10.2147/ott.s91560] [Cited by in Crossref: 9] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
45 Zhang J, Rong L, Shao J, Zhang Y, Liu Y, Zhao S, Li L, Yu W, Zhang M, Ren X, Zhao Q, Zhu C, Luo H, Zang W, Cao J. Epigenetic restoration of voltage-gated potassium channel Kv1.2 alleviates nerve injury-induced neuropathic pain. J Neurochem 2021;156:367-78. [PMID: 32621322 DOI: 10.1111/jnc.15117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
46 Sakai NS, Samia-Aly E, Barbera M, Fitzgerald RC. A review of the current understanding and clinical utility of miRNAs in esophageal cancer. Semin Cancer Biol. 2013;23:512-521. [PMID: 24013023 DOI: 10.1016/j.semcancer.2013.08.005] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 9.1] [Reference Citation Analysis]
47 Neill D. A proposal in relation to a genetic control of lifespan in mammals. Ageing Research Reviews 2010;9:437-46. [DOI: 10.1016/j.arr.2010.05.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
48 Chou CH, Chang NW, Shrestha S, Hsu SD, Lin YL, Lee WH, Yang CD, Hong HC, Wei TY, Tu SJ, Tsai TR, Ho SY, Jian TY, Wu HY, Chen PR, Lin NC, Huang HT, Yang TL, Pai CY, Tai CS, Chen WL, Huang CY, Liu CC, Weng SL, Liao KW, Hsu WL, Huang HD. miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database. Nucleic Acids Res. 2016;44:D239-D247. [PMID: 26590260 DOI: 10.1093/nar/gkv1258] [Cited by in Crossref: 718] [Cited by in F6Publishing: 601] [Article Influence: 119.7] [Reference Citation Analysis]
49 Lewandoski M. Analysis of Mouse Development with Conditional Mutagenesis. In: Feil R, Metzger D, editors. Conditional Mutagenesis: An Approach to Disease Models. Berlin: Springer Berlin Heidelberg; 2007. pp. 235-62. [DOI: 10.1007/978-3-540-35109-2_10] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
50 Duan Z, Person RE, Lee HH, Huang S, Donadieu J, Badolato R, Grimes HL, Papayannopoulou T, Horwitz MS. Epigenetic regulation of protein-coding and microRNA genes by the Gfi1-interacting tumor suppressor PRDM5. Mol Cell Biol. 2007;27:6889-6902. [PMID: 17636019 DOI: 10.1128/mcb.00762-07] [Cited by in Crossref: 61] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
51 Bendoraite A, Knouf EC, Garg KS, Parkin RK, Kroh EM, O'Briant KC, Ventura AP, Godwin AK, Karlan BY, Drescher CW, Urban N, Knudsen BS, Tewari M. Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition. Gynecol Oncol 2010;116:117-25. [PMID: 19854497 DOI: 10.1016/j.ygyno.2009.08.009] [Cited by in Crossref: 138] [Cited by in F6Publishing: 129] [Article Influence: 11.5] [Reference Citation Analysis]
52 Handschuh L. Not Only Mutations Matter: Molecular Picture of Acute Myeloid Leukemia Emerging from Transcriptome Studies. J Oncol 2019;2019:7239206. [PMID: 31467542 DOI: 10.1155/2019/7239206] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
53 Noguchi S, Mori T, Otsuka Y, Yamada N, Yasui Y, Iwasaki J, Kumazaki M, Maruo K, Akao Y. Anti-oncogenic microRNA-203 induces senescence by targeting E2F3 protein in human melanoma cells. J Biol Chem 2012;287:11769-77. [PMID: 22354972 DOI: 10.1074/jbc.M111.325027] [Cited by in Crossref: 83] [Cited by in F6Publishing: 43] [Article Influence: 9.2] [Reference Citation Analysis]
54 Wang J, Haubrock M, Cao KM, Hua X, Zhang CY, Wingender E, Li J. Regulatory coordination of clustered microRNAs based on microRNA-transcription factor regulatory network. BMC Syst Biol 2011;5:199. [PMID: 22176772 DOI: 10.1186/1752-0509-5-199] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
55 Rameshwar P. Current thoughts on the therapeutic potential of stem cell. Methods Mol Biol 2012;879:3-26. [PMID: 22610550 DOI: 10.1007/978-1-61779-815-3_1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
56 Tang HL, Zhu JH. Epigenetics and neural stem cell commitment. Neurosci Bull 2007;23:241-8. [PMID: 17687400 DOI: 10.1007/s12264-007-0036-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
57 Barmack NH, Qian Z, Yakhnitsa V. Long-term climbing fibre activity induces transcription of microRNAs in cerebellar Purkinje cells. Philos Trans R Soc Lond B Biol Sci 2014;369:20130508. [PMID: 25135969 DOI: 10.1098/rstb.2013.0508] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
58 Garzon R, Heaphy CE, Havelange V, Fabbri M, Volinia S, Tsao T, Zanesi N, Kornblau SM, Marcucci G, Calin GA, Andreeff M, Croce CM. MicroRNA 29b functions in acute myeloid leukemia. Blood 2009;114:5331-41. [PMID: 19850741 DOI: 10.1182/blood-2009-03-211938] [Cited by in Crossref: 329] [Cited by in F6Publishing: 295] [Article Influence: 27.4] [Reference Citation Analysis]
59 Lages E, Ipas H, Guttin A, Nesr H, Berger F, Issartel JP. MicroRNAs: molecular features and role in cancer. Front Biosci (Landmark Ed). 2012;17:2508-2540. [PMID: 22652795 DOI: 10.2741/4068] [Cited by in Crossref: 128] [Cited by in F6Publishing: 113] [Article Influence: 14.2] [Reference Citation Analysis]
60 Valeri N, Vannini I, Fanini F, Calore F, Adair B, Fabbri M. Epigenetics, miRNAs, and human cancer: a new chapter in human gene regulation. Mamm Genome 2009;20:573-80. [PMID: 19697081 DOI: 10.1007/s00335-009-9206-5] [Cited by in Crossref: 68] [Cited by in F6Publishing: 57] [Article Influence: 5.7] [Reference Citation Analysis]
61 Chaudhuri K, Chatterjee R. MicroRNA detection and target prediction: integration of computational and experimental approaches. DNA Cell Biol 2007;26:321-37. [PMID: 17504028 DOI: 10.1089/dna.2006.0549] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 4.4] [Reference Citation Analysis]
62 Tang F, Hajkova P, Barton SC, O'Carroll D, Lee C, Lao K, Surani MA. 220-plex microRNA expression profile of a single cell. Nat Protoc 2006;1:1154-9. [PMID: 17406397 DOI: 10.1038/nprot.2006.161] [Cited by in Crossref: 74] [Cited by in F6Publishing: 60] [Article Influence: 5.3] [Reference Citation Analysis]
63 Tian Y, Li G, Bu X, Shen J, Tao Z, Chen L, Zeng T, Du X, Lu L. Changes in morphology and miRNAs expression in small intestines of Shaoxing ducks in response to high temperature. Mol Biol Rep 2019;46:3843-56. [PMID: 31049835 DOI: 10.1007/s11033-019-04827-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
64 Fabbri M, Croce CM, Calin GA. MicroRNAs. Cancer J. 2008;14:1-6. [PMID: 18303474 DOI: 10.1097/ppo.0b013e318164145e] [Cited by in Crossref: 141] [Cited by in F6Publishing: 85] [Article Influence: 10.8] [Reference Citation Analysis]
65 Safarzadeh E, Asadzadeh Z, Safaei S, Hatefi A, Derakhshani A, Giovannelli F, Brunetti O, Silvestris N, Baradaran B. MicroRNAs and lncRNAs-A New Layer of Myeloid-Derived Suppressor Cells Regulation. Front Immunol 2020;11:572323. [PMID: 33133086 DOI: 10.3389/fimmu.2020.572323] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
66 Shi D, Li P, Ma L, Zhong D, Chu H, Yan F, Lv Q, Qin C, Wang W, Wang M, Tong N, Zhang Z, Yin C. A genetic variant in pre-miR-27a is associated with a reduced renal cell cancer risk in a Chinese population. PLoS One 2012;7:e46566. [PMID: 23118855 DOI: 10.1371/journal.pone.0046566] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
67 Wang G, Dong F, Xu Z, Sharma S, Hu X, Chen D, Zhang L, Zhang J, Dong Q. MicroRNA profile in HBV-induced infection and hepatocellular carcinoma. BMC Cancer. 2017;17:805. [PMID: 29191172 DOI: 10.1186/s12885-017-3816-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 11.0] [Reference Citation Analysis]
68 Imanaka Y, Tsuchiya S, Sato F, Shimada Y, Shimizu K, Tsujimoto G. MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma. J Hum Genet 2011;56:270-6. [DOI: 10.1038/jhg.2011.1] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 6.3] [Reference Citation Analysis]
69 Wang H, Wu Q, Zhang Y, Zhang HN, Wang YB, Wang W. TGF-β1-induced epithelial-mesenchymal transition in lung cancer cells involves upregulation of miR-9 and downregulation of its target, E-cadherin. Cell Mol Biol Lett 2017;22:22. [PMID: 29118814 DOI: 10.1186/s11658-017-0053-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
70 Iio A, Nakagawa Y, Hirata I, Naoe T, Akao Y. Identification of non-coding RNAs embracing microRNA-143/145 cluster. Mol Cancer 2010;9:136. [PMID: 20525177 DOI: 10.1186/1476-4598-9-136] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 5.2] [Reference Citation Analysis]
71 Shih KK, Levine DA. Exosomal microRNAs step into the biomarker arena. Gynecol Oncol. 2008;110:1-2. [PMID: 18589207 DOI: 10.1016/j.ygyno.2008.05.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
72 Mizuguchi Y, Takizawa T, Yoshida H, Uchida E. Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review. Hepatol Res. 2016;46:391-406. [PMID: 26490438 DOI: 10.1111/hepr.12606] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 10.8] [Reference Citation Analysis]
73 Kozaki K, Inazawa J. Tumor-suppressive microRNA silenced by tumor-specific DNA hypermethylation in cancer cells. Cancer Sci. 2012;103:837-845. [PMID: 22320679 DOI: 10.1111/j.1349-7006.2012.02236.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
74 de Freitas AC, Coimbra EC, Leitão Mda C. Molecular targets of HPV oncoproteins: potential biomarkers for cervical carcinogenesis. Biochim Biophys Acta 2014;1845:91-103. [PMID: 24388872 DOI: 10.1016/j.bbcan.2013.12.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
75 Guo L, Li W, Hu L, Zhou H, Zheng L, Yu L, Liang W. Diagnostic value of circulating microRNAs for liver cirrhosis: a meta-analysis. Oncotarget. 2018;9:5397-5405. [PMID: 29435187 DOI: 10.18632/oncotarget.23332] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
76 Singh MK, Lu MM, Massera D, Epstein JA. MicroRNA-processing enzyme Dicer is required in epicardium for coronary vasculature development. J Biol Chem 2011;286:41036-45. [PMID: 21969379 DOI: 10.1074/jbc.M111.268573] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
77 Lin YC, Huang HY, Shrestha S, Chou CH, Chen YH, Chen CR, Hong HC, Li J, Chang YA, Chiew MY, Huang YR, Tu SJ, Sun TH, Weng SL, Tseng CP, Huang HD. Multi-omics profiling reveals microRNA-mediated insulin signaling networks. BMC Bioinformatics 2020;21:389. [PMID: 32938376 DOI: 10.1186/s12859-020-03678-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Ruiz AJ, Russell SJ. MicroRNAs and oncolytic viruses. Curr Opin Virol. 2015;13:40-48. [PMID: 25863717 DOI: 10.1016/j.coviro.2015.03.007] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
79 Reyes ME, Riquelme I, Salvo T, Zanella L, Letelier P, Brebi P. Brown Seaweed Fucoidan in Cancer: Implications in Metastasis and Drug Resistance. Mar Drugs 2020;18:E232. [PMID: 32354032 DOI: 10.3390/md18050232] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
80 Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem. 2009;284:3728-3738. [PMID: 19088079 DOI: 10.1074/jbc.m808788200] [Cited by in Crossref: 238] [Cited by in F6Publishing: 139] [Article Influence: 18.3] [Reference Citation Analysis]
81 Acunzo M, Romano G, Wernicke D, Croce CM. MicroRNA and cancer--a brief overview. Adv Biol Regul. 2015;57:1-9. [PMID: 25294678 DOI: 10.1016/j.jbior.2014.09.013] [Cited by in Crossref: 304] [Cited by in F6Publishing: 297] [Article Influence: 43.4] [Reference Citation Analysis]
82 Vecchione A, Belletti B, Lovat F, Volinia S, Chiappetta G, Giglio S, Sonego M, Cirombella R, Onesti EC, Pellegrini P, Califano D, Pignata S, Losito S, Canzonieri V, Sorio R, Alder H, Wernicke D, Stoppacciaro A, Baldassarre G, Croce CM. A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis. Proc Natl Acad Sci U S A 2013;110:9845-50. [PMID: 23697367 DOI: 10.1073/pnas.1305472110] [Cited by in Crossref: 138] [Cited by in F6Publishing: 115] [Article Influence: 17.3] [Reference Citation Analysis]
83 Kang M, Shi J, Peng N, He S. MicroRNA-211 promotes non-small-cell lung cancer proliferation and invasion by targeting MxA. Onco Targets Ther. 2017;10:5667-5675. [PMID: 29238200 DOI: 10.2147/ott.s143084] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
84 Namihira M, Kohyama J, Abematsu M, Nakashima K. Epigenetic mechanisms regulating fate specification of neural stem cells. Philos Trans R Soc Lond B Biol Sci 2008;363:2099-109. [PMID: 18375376 DOI: 10.1098/rstb.2008.2262] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 4.3] [Reference Citation Analysis]
85 Zhou Y, Huang Q, Gao J, Lu J, Shen X, Fan C. A dumbbell probe-mediated rolling circle amplification strategy for highly sensitive microRNA detection. Nucleic Acids Res 2010;38:e156. [PMID: 20547593 DOI: 10.1093/nar/gkq556] [Cited by in Crossref: 149] [Cited by in F6Publishing: 131] [Article Influence: 13.5] [Reference Citation Analysis]
86 Coutinho LL, Matukumalli LK, Sonstegard TS, Van Tassell CP, Gasbarre LC, Capuco AV, Smith TP. Discovery and profiling of bovine microRNAs from immune-related and embryonic tissues. Physiol Genomics. 2007;29:35-43. [PMID: 17105755 DOI: 10.1152/physiolgenomics.00081.2006] [Cited by in Crossref: 73] [Cited by in F6Publishing: 73] [Article Influence: 4.9] [Reference Citation Analysis]
87 Noguchi S, Iwasaki J, Kumazaki M, Mori T, Maruo K, Sakai H, Yamada N, Shimada K, Naoe T, Kitade Y, Akao Y. Chemically modified synthetic microRNA-205 inhibits the growth of melanoma cells in vitro and in vivo. Mol Ther 2013;21:1204-11. [PMID: 23629002 DOI: 10.1038/mt.2013.70] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 5.3] [Reference Citation Analysis]
88 Xu X, Dong Z, Li Y, Yang Y, Yuan Z, Qu X, Kong B. The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimulation. Int J Biochem Cell Biol 2013;45:536-45. [PMID: 23262295 DOI: 10.1016/j.biocel.2012.12.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
89 Nicoloso MS, Kipps TJ, Croce CM, Calin GA. MicroRNAs in the pathogeny of chronic lymphocytic leukaemia. Br J Haematol 2007;139:709-16. [DOI: 10.1111/j.1365-2141.2007.06868.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
90 Tong AW, Nemunaitis J. Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Ther. 2008;15:341-355. [PMID: 18369380 DOI: 10.1038/cgt.2008.8] [Cited by in Crossref: 159] [Cited by in F6Publishing: 144] [Article Influence: 12.2] [Reference Citation Analysis]
91 Giza DE, Calin GA. microRNA and Chronic Lymphocytic Leukemia. Adv Exp Med Biol 2015;889:23-40. [PMID: 26658994 DOI: 10.1007/978-3-319-23730-5_2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
92 Kanokudom S, Vilaivan T, Wikan N, Thepparit C, Smith DR, Assavalapsakul W. miR-21 promotes dengue virus serotype 2 replication in HepG2 cells. Antiviral Res 2017;142:169-77. [PMID: 28365456 DOI: 10.1016/j.antiviral.2017.03.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
93 Geisler A, Fechner H. MicroRNA-regulated viral vectors for gene therapy. World J Exp Med 2016;6:37-54. [PMID: 27226955 DOI: 10.5493/wjem.v6.i2.37] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 32] [Article Influence: 7.4] [Reference Citation Analysis]
94 Jiang X, Li X, Wu F, Gao H, Wang G, Zheng H, Wang H, Li J, Chen C. Overexpression of miR-92a promotes the tumor growth of osteosarcoma by suppressing F-box and WD repeat-containing protein 7. Gene 2017;606:10-6. [PMID: 28069547 DOI: 10.1016/j.gene.2017.01.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
95 Lai J, Wang H, Pan Z, Su F. A novel six-microRNA-based model to improve prognosis prediction of breast cancer. Aging (Albany NY) 2019;11:649-62. [PMID: 30696800 DOI: 10.18632/aging.101767] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 22.0] [Reference Citation Analysis]
96 Kan H, Guo W, Huang Y, Liu D. MicroRNA-520g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7. FEBS Lett. 2015;589:102-109. [PMID: 25436421 DOI: 10.1016/j.febslet.2014.11.031] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
97 Dar AA, Majid S, de Semir D, Nosrati M, Bezrookove V, Kashani-Sabet M. miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein. J Biol Chem. 2011;286:16606-16614. [PMID: 21454583 DOI: 10.1074/jbc.m111.227611] [Cited by in Crossref: 170] [Cited by in F6Publishing: 89] [Article Influence: 17.0] [Reference Citation Analysis]
98 Mizuguchi Y, Mishima T, Yokomuro S, Arima Y, Kawahigashi Y, Shigehara K, Kanda T, Yoshida H, Uchida E, Tajiri T. Sequencing and bioinformatics-based analyses of the microRNA transcriptome in hepatitis B-related hepatocellular carcinoma. PLoS One. 2011;6:e15304. [PMID: 21283620 DOI: 10.1371/journal.pone.0015304] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 5.3] [Reference Citation Analysis]
99 Zhang J, Yang B, Ying B, Li D, Shi Y, Song X, Cai B, Huang Z, Wu Y, Wang L. Association of pre-microRNAs genetic variants with susceptibility in systemic lupus erythematosus. Mol Biol Rep 2011;38:1463-8. [PMID: 20845080 DOI: 10.1007/s11033-010-0252-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
100 Tili E, Michaille JJ, Gandhi V, Plunkett W, Sampath D, Calin GA. miRNAs and their potential for use against cancer and other diseases. Future Oncol 2007;3:521-37. [PMID: 17927518 DOI: 10.2217/14796694.3.5.521] [Cited by in Crossref: 82] [Cited by in F6Publishing: 73] [Article Influence: 6.3] [Reference Citation Analysis]
101 Sheng X, Chen H, Wang H, Ding Z, Xu G, Zhang J, Lu W, Wu T, Zhao L. MicroRNA-130b promotes cell migration and invasion by targeting peroxisome proliferator-activated receptor gamma in human glioma. Biomed Pharmacother 2015;76:121-6. [PMID: 26653558 DOI: 10.1016/j.biopha.2015.10.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
102 Noguchi S, Kumazaki M, Mori T, Baba K, Okuda M, Mizuno T, Akao Y. Analysis of microRNA-203 function in CREB/MITF/RAB27a pathway: comparison between canine and human melanoma cells. Vet Comp Oncol 2016;14:384-94. [PMID: 25280339 DOI: 10.1111/vco.12118] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
103 Mitra R, Bandyopadhyay S, Maulik U, Zhang MQ. SFSSClass: an integrated approach for miRNA based tumor classification. BMC Bioinformatics 2010;11 Suppl 1:S22. [PMID: 20122194 DOI: 10.1186/1471-2105-11-S1-S22] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
104 Russo G, Giordano A. miRNAs: from biogenesis to networks. Methods Mol Biol 2009;563:303-52. [PMID: 19597793 DOI: 10.1007/978-1-60761-175-2_17] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
105 Lee C, He H, Jiang Y, Di Y, Yang F, Li J, Jin C, Fu D. Elevated expression of tumor miR-222 in pancreatic cancer is associated with Ki67 and poor prognosis. Med Oncol 2013;30. [DOI: 10.1007/s12032-013-0700-y] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 4.5] [Reference Citation Analysis]
106 Czubak K, Lewandowska MA, Klonowska K, Roszkowski K, Kowalewski J, Figlerowicz M, Kozlowski P. High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer. Oncotarget 2015;6:23399-416. [PMID: 26156018 DOI: 10.18632/oncotarget.4351] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 7.6] [Reference Citation Analysis]
107 Trakanant S, Nihara J, Nagai T, Kawasaki M, Kawasaki K, Ishida Y, Meguro F, Kudo T, Yamada A, Maeda T, Saito I, Ohazama A. MicroRNAs regulate distal region of mandibular development through Hh signaling. J Anat 2021;238:711-9. [PMID: 33011977 DOI: 10.1111/joa.13328] [Reference Citation Analysis]
108 Liu BL, Sun KX, Zong ZH, Chen S, Zhao Y. MicroRNA-372 inhibits endometrial carcinoma development by targeting the expression of the Ras homolog gene family member C (RhoC). Oncotarget 2016;7:6649-64. [PMID: 26673619 DOI: 10.18632/oncotarget.6544] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
109 Uchino K, Ochiya T, Takeshita F. RNAi therapeutics and applications of microRNAs in cancer treatment. Jpn J Clin Oncol 2013;43:596-607. [PMID: 23592885 DOI: 10.1093/jjco/hyt052] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
110 Seio K, Takaku Y, Miyazaki K, Kurohagi S, Masaki Y, Ohkubo A, Sekine M. Synthesis of terminally modified oligonucleotides and their hybridization dependence on the size of the target RNAs. Org Biomol Chem 2009;7:2440-51. [PMID: 19462056 DOI: 10.1039/b900301k] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
111 Zhang MY, Li SH, Huang GL, Lin GH, Shuang ZY, Lao XM, Xu L, Lin XJ, Wang HY, Li SP. Identification of a novel microRNA signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis. BMC Cancer. 2015;15:64. [PMID: 25880914 DOI: 10.1186/s12885-015-1067-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
112 Gissi DB, Morandi L, Gabusi A, Tarsitano A, Marchetti C, Cura F, Palmieri A, Montebugnoli L, Asioli S, Foschini MP, Scapoli L. A Noninvasive Test for MicroRNA Expression in Oral Squamous Cell Carcinoma. Int J Mol Sci 2018;19:E1789. [PMID: 29914173 DOI: 10.3390/ijms19061789] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
113 Garzon R, Croce CM. MicroRNAs and cancer: introduction. Semin Oncol 2011;38:721-3. [PMID: 22082757 DOI: 10.1053/j.seminoncol.2011.08.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
114 Lin CC, Jiang W, Mitra R, Cheng F, Yu H, Zhao Z. Regulation rewiring analysis reveals mutual regulation between STAT1 and miR-155-5p in tumor immunosurveillance in seven major cancers. Sci Rep 2015;5:12063. [PMID: 26156524 DOI: 10.1038/srep12063] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
115 Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857-866. [PMID: 17060945 DOI: 10.1038/nrc1997] [Cited by in Crossref: 5257] [Cited by in F6Publishing: 4861] [Article Influence: 375.5] [Reference Citation Analysis]
116 D'Anzeo M, Faloppi L, Scartozzi M, Giampieri R, Bianconi M, Del Prete M, Silvestris N, Cascinu S. The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment. Molecules. 2014;19:6393-6406. [PMID: 24853455 DOI: 10.3390/molecules19056393] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 6.4] [Reference Citation Analysis]
117 Chen J, Zmijewska A, Zhi D, Mannon RB. Cyclosporine-mediated allograft fibrosis is associated with micro-RNA-21 through AKT signaling. Transpl Int 2015;28:232-45. [DOI: 10.1111/tri.12471] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
118 Marquez RT, McCaffrey AP. Advances in microRNAs: implications for gene therapists. Hum Gene Ther. 2008;19:27-38. [PMID: 18092919 DOI: 10.1089/hum.2007.147] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
119 Matuszcak C, Haier J, Hummel R, Lindner K. MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential. World J Gastroenterol 2014;20:13658-66. [PMID: 25320504 DOI: 10.3748/wjg.v20.i38.13658] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
120 Le BH, Seo YJ. Direct incorporation and extension of a fluorescent nucleotide through rolling circle DNA amplification for the detection of microRNA 24-3P. Bioorg Med Chem Lett 2018;28:2035-8. [PMID: 29709251 DOI: 10.1016/j.bmcl.2018.04.058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
121 Bertoni N, Pereira LM, Severino FE, Moura R, Yoshida WB, Reis PP. Integrative meta-analysis identifies microRNA-regulated networks in infantile hemangioma. BMC Med Genet 2016;17:4. [PMID: 26772808 DOI: 10.1186/s12881-015-0262-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
122 Noguchi S, Yasui Y, Iwasaki J, Kumazaki M, Yamada N, Naito S, Akao Y. Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways. Cancer Lett. 2013;328:353-361. [PMID: 23104321 DOI: 10.1016/j.canlet.2012.10.017] [Cited by in Crossref: 92] [Cited by in F6Publishing: 87] [Article Influence: 10.2] [Reference Citation Analysis]
123 Fabbri M, Croce CM. Role of microRNAs in lymphoid biology and disease. Curr Opin Hematol 2011;18:266-72. [PMID: 21519241 DOI: 10.1097/MOH.0b013e3283476012] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 4.1] [Reference Citation Analysis]
124 Brodetskyi IS, Malanchuk VO, Dosenko VE. Expressions of microRNA-29a and microRNA-34a in pleomorphic adenomas of salivary glands. Gland Surg 2020;9:1914-23. [PMID: 33447542 DOI: 10.21037/gs-20-284] [Reference Citation Analysis]
125 Bhattacharya M, Sharma AR, Sharma G, Patra BC, Nam JS, Chakraborty C, Lee SS. The crucial role and regulations of miRNAs in zebrafish development. Protoplasma 2017;254:17-31. [PMID: 26820151 DOI: 10.1007/s00709-015-0931-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 4.4] [Reference Citation Analysis]
126 Kozaki K, Inazawa J. Tumor-suppressive microRNA silenced by tumor-specific DNA hypermethylation in cancer cells. Cancer Sci. 2012;103:837-845. [PMID: 22320679 DOI: 10.1111/j.1349-7006. 2012.02236.x] [Reference Citation Analysis]
127 Balatti V, Pekarky Y, Rizzotto L, Croce CM. miR deregulation in CLL. Adv Exp Med Biol 2013;792:309-25. [PMID: 24014303 DOI: 10.1007/978-1-4614-8051-8_14] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
128 Miceli M, Bontempo P, Nebbioso A, Altucci L. Natural compounds in epigenetics: a current view. Food Chem Toxicol 2014;73:71-83. [PMID: 25139119 DOI: 10.1016/j.fct.2014.08.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
129 Mishra SR. Significance of molecular chaperones and micro RNAs in acquisition of thermo-tolerance in dairy cattle. Anim Biotechnol 2020;:1-11. [PMID: 33121378 DOI: 10.1080/10495398.2020.1830788] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
130 Meola N, Gennarino VA, Banfi S. microRNAs and genetic diseases. Pathogenetics 2009;2:7. [PMID: 19889204 DOI: 10.1186/1755-8417-2-7] [Cited by in Crossref: 105] [Cited by in F6Publishing: 91] [Article Influence: 8.8] [Reference Citation Analysis]
131 Zou X, Xia T, Li M, Wang T, Liu P, Zhou X, Huang Z, Zhu W. MicroRNA profiling in serum: Potential signatures for breast cancer diagnosis. Cancer Biomark 2021;30:41-53. [PMID: 32894240 DOI: 10.3233/CBM-201547] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
132 Fabbri M, Ivan M, Cimmino A, Negrini M, Calin GA. Regulatory mechanisms of microRNAs involvement in cancer. Expert Opin Biol Ther 2007;7:1009-19. [PMID: 17665990 DOI: 10.1517/14712598.7.7.1009] [Cited by in Crossref: 111] [Cited by in F6Publishing: 100] [Article Influence: 7.9] [Reference Citation Analysis]
133 Paul S, Vera J. Rough hypercuboid based supervised clustering of miRNAs. Mol Biosyst 2015;11:2068-81. [PMID: 25996345 DOI: 10.1039/c5mb00213c] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
134 Tufekci KU, Oner MG, Genc S, Genc K. MicroRNAs and Multiple Sclerosis. Autoimmune Dis 2010;2011:807426. [PMID: 21188194 DOI: 10.4061/2011/807426] [Cited by in Crossref: 20] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
135 McLoughlin HS, Fineberg SK, Ghosh LL, Tecedor L, Davidson BL. Dicer is required for proliferation, viability, migration and differentiation in corticoneurogenesis. Neuroscience 2012;223:285-95. [PMID: 22898830 DOI: 10.1016/j.neuroscience.2012.08.009] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
136 How C, Pintilie M, Bruce JP, Hui AB, Clarke BA, Wong P, Yin S, Yan R, Waggott D, Boutros PC, Fyles A, Hedley DW, Hill RP, Milosevic M, Liu FF. Developing a prognostic micro-RNA signature for human cervical carcinoma. PLoS One 2015;10:e0123946. [PMID: 25880806 DOI: 10.1371/journal.pone.0123946] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
137 Noguchi S, Mori T, Nakagawa T, Itamoto K, Haraguchi T, Mizuno T. DNA methylation contributes toward silencing of antioncogenic microRNA-203 in human and canine melanoma cells. Melanoma Res 2015;25:390-8. [PMID: 26225581 DOI: 10.1097/CMR.0000000000000183] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 3.8] [Reference Citation Analysis]
138 Maldonado L, Hoque MO. Epigenomics and ovarian carcinoma. Biomark Med 2010;4:543-70. [PMID: 20701443 DOI: 10.2217/bmm.10.72] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
139 Zou C, Chen J, Chen K, Wang S, Cao Y, Zhang J, Sheng Y, Huang A, Tang H. Functional analysis of miR-181a and Fas involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis. Exp Cell Res 2015;331:352-61. [PMID: 25449696 DOI: 10.1016/j.yexcr.2014.11.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
140 Ma H, Lin Y, Zhao ZA, Lu X, Yu Y, Zhang X, Wang Q, Li L. MicroRNA-127 Promotes Mesendoderm Differentiation of Mouse Embryonic Stem Cells by Targeting Left-Right Determination Factor 2. J Biol Chem 2016;291:12126-35. [PMID: 27072135 DOI: 10.1074/jbc.M116.723247] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
141 Min A, Zhu C, Peng S, Rajthala S, Costea DE, Sapkota D. MicroRNAs as Important Players and Biomarkers in Oral Carcinogenesis. Biomed Res Int. 2015;2015:186904. [PMID: 26504785 DOI: 10.1155/2015/186904] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 7.2] [Reference Citation Analysis]
142 Wang YM, Trinh MP, Zheng Y, Guo K, Jimenez LA, Zhong W. Analysis of circulating non-coding RNAs in a non-invasive and cost-effective manner. Trends Analyt Chem 2019;117:242-62. [PMID: 32292220 DOI: 10.1016/j.trac.2019.07.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
143 Pinter R, Hindges R. Perturbations of microRNA function in mouse dicer mutants produce retinal defects and lead to aberrant axon pathfinding at the optic chiasm. PLoS One 2010;5:e10021. [PMID: 20386732 DOI: 10.1371/journal.pone.0010021] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 5.5] [Reference Citation Analysis]
144 Zhang DQ, Zhou CK, Jiang XW, Chen J, Shi BK. Increased expression of miR-222 is associated with poor prognosis in bladder cancer. World J Surg Oncol 2014;12:241. [PMID: 25078265 DOI: 10.1186/1477-7819-12-241] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
145 Zhou L, He H, Mi JX, Li C, Lee B, Mi QS. MicroRNA genes. Ann N Y Acad Sci 2008;1150:72-5. [PMID: 19120271 DOI: 10.1196/annals.1447.026] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
146 Ma Z, Qi J, Meng S, Wen B, Zhang J. Swimming exercise training-induced left ventricular hypertrophy involves microRNAs and synergistic regulation of the PI3K/AKT/mTOR signaling pathway. Eur J Appl Physiol 2013;113:2473-86. [DOI: 10.1007/s00421-013-2685-9] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 7.5] [Reference Citation Analysis]
147 Su JL, Chen PB, Chen YH, Chen SC, Chang YW, Jan YH, Cheng X, Hsiao M, Hung MC. Downregulation of microRNA miR-520h by E1A contributes to anticancer activity. Cancer Res 2010;70:5096-108. [PMID: 20501832 DOI: 10.1158/0008-5472.CAN-09-4148] [Cited by in Crossref: 48] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
148 Chatterjee V, Beard RS Jr, Reynolds JJ, Haines R, Guo M, Rubin M, Guido J, Wu MH, Yuan SY. MicroRNA-147b regulates vascular endothelial barrier function by targeting ADAM15 expression. PLoS One 2014;9:e110286. [PMID: 25333931 DOI: 10.1371/journal.pone.0110286] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
149 Lancman JJ, Caruccio NC, Harfe BD, Pasquinelli AE, Schageman JJ, Pertsemlidis A, Fallon JF. Analysis of the regulation of lin-41 during chick and mouse limb development. Dev Dyn 2005;234:948-60. [DOI: 10.1002/dvdy.20591] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
150 Sengar GS, Deb R, Singh U, Raja TV, Kant R, Sajjanar B, Alex R, Alyethodi RR, Kumar A, Kumar S, Singh R, Jakhesara SJ, Joshi CG. Differential expression of microRNAs associated with thermal stress in Frieswal (Bos taurus x Bos indicus) crossbred dairy cattle. Cell Stress Chaperones 2018;23:155-70. [PMID: 28776223 DOI: 10.1007/s12192-017-0833-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
151 Sandhu S, Garzon R. Potential applications of microRNAs in cancer diagnosis, prognosis, and treatment. Semin Oncol 2011;38:781-7. [PMID: 22082764 DOI: 10.1053/j.seminoncol.2011.08.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
152 Zhu H, Wu H, Liu X, Li B, Chen Y, Ren X, Liu CG, Yang JM. Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells. Autophagy. 2009;5:816-823. [PMID: 19535919 DOI: 10.4161/auto.9064] [Cited by in Crossref: 313] [Cited by in F6Publishing: 291] [Article Influence: 26.1] [Reference Citation Analysis]
153 Meng W, Jiang L, Lu L, Hu H, Yu H, Ding D, Xiao K, Zheng W, Guo H, Ma W. Anti-miR-155 oligonucleotide enhances chemosensitivity of U251 cell to taxol by inducing apoptosis. Cell Biol Int 2012;36:653-9. [PMID: 22276743 DOI: 10.1042/CBI20100918] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
154 Xu J, Yin Z, Shen H, Gao W, Qian Y, Pei D, Liu L, Shu Y. A genetic polymorphism in pre-miR-27a confers clinical outcome of non-small cell lung cancer in a Chinese population. PLoS One 2013;8:e79135. [PMID: 24223174 DOI: 10.1371/journal.pone.0079135] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
155 Li G, Luo J, Xiao Q, Liang C, Ding P. Predicting microRNA-disease associations using label propagation based on linear neighborhood similarity. J Biomed Inform 2018;82:169-77. [PMID: 29763707 DOI: 10.1016/j.jbi.2018.05.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 10.3] [Reference Citation Analysis]
156 Kim BM, Choi MY. Non-canonical microRNAs miR-320 and miR-702 promote proliferation in Dgcr8-deficient embryonic stem cells. Biochem Biophys Res Commun 2012;426:183-9. [PMID: 22925886 DOI: 10.1016/j.bbrc.2012.08.058] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
157 Lu Y, Zhou Y, Qu W, Deng M, Zhang C. A Lasso regression model for the construction of microRNA-target regulatory networks. Bioinformatics 2011;27:2406-13. [PMID: 21743061 DOI: 10.1093/bioinformatics/btr410] [Cited by in Crossref: 83] [Cited by in F6Publishing: 56] [Article Influence: 8.3] [Reference Citation Analysis]
158 Tamaru S, Kajihara T, Mizuno Y, Mizuno Y, Tochigi H, Ishihara O. Endometrial microRNAs and their aberrant expression patterns. Med Mol Morphol 2020;53:131-40. [PMID: 32350620 DOI: 10.1007/s00795-020-00252-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
159 Yang X, Pang YY, He RQ, Lin P, Cen JM, Yang H, Ma J, Chen G. Diagnostic value of strand-specific miRNA-101-3p and miRNA-101-5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action. FEBS Open Bio 2018;8:64-84. [PMID: 29321958 DOI: 10.1002/2211-5463.12349] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
160 Turcatel G, Rubin N, El-Hashash A, Warburton D. MIR-99a and MIR-99b modulate TGF-β induced epithelial to mesenchymal plasticity in normal murine mammary gland cells. PLoS One 2012;7:e31032. [PMID: 22299047 DOI: 10.1371/journal.pone.0031032] [Cited by in Crossref: 83] [Cited by in F6Publishing: 76] [Article Influence: 9.2] [Reference Citation Analysis]
161 Zhu W, Shan X, Wang T, Shu Y, Liu P. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int J Cancer. 2010;127:2520-2529. [PMID: 20162574 DOI: 10.1002/ijc.25260] [Cited by in Crossref: 205] [Cited by in F6Publishing: 190] [Article Influence: 18.6] [Reference Citation Analysis]
162 Malczewska A, Kidd M, Matar S, Kos-Kudla B, Modlin IM. A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors. Neuroendocrinology. 2018;107:73-90. [PMID: 29566385 DOI: 10.1159/000487326] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 11.0] [Reference Citation Analysis]
163 Tchatchou S, Jung A, Hemminki K, Sutter C, Wappenschmidt B, Bugert P, Weber BH, Niederacher D, Arnold N, Varon-Mateeva R, Ditsch N, Meindl A, Schmutzler RK, Bartram CR, Burwinkel B. A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. Carcinogenesis 2009;30:59-64. [PMID: 19028706 DOI: 10.1093/carcin/bgn253] [Cited by in Crossref: 68] [Cited by in F6Publishing: 54] [Article Influence: 5.2] [Reference Citation Analysis]
164 Wan G, Lim QE, Too HP. High-performance quantification of mature microRNAs by real-time RT-PCR using deoxyuridine-incorporated oligonucleotides and hemi-nested primers. RNA 2010;16:1436-45. [PMID: 20547774 DOI: 10.1261/rna.2001610] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
165 Kirimura S, Kurata M, Nakagawa Y, Onishi I, Abe-Suzuki S, Abe S, Yamamoto K, Kitagawa M. Role of microRNA-29b in myelodysplastic syndromes during transformation to overt leukaemia. Pathology 2016;48:233-41. [PMID: 27020498 DOI: 10.1016/j.pathol.2016.02.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
166 Davison TS, Johnson CD, Andruss BF. [2] Analyzing Micro‐RNA Expression Using Microarrays. DNA Microarrays, Part B: Databases and Statistics. Elsevier; 2006. pp. 14-34. [DOI: 10.1016/s0076-6879(06)11002-2] [Cited by in Crossref: 58] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
167 Yoshikawa R, Mori T, Noguchi S, Akao Y, Maruo K, Kitade Y. Synthetic microRNA-205 exhibited tumour suppression in spontaneous canine malignant melanoma by intratumoral injection. Vet Comp Oncol 2019;17:407-12. [PMID: 31020761 DOI: 10.1111/vco.12485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
168 Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S, Hong L, Liu J, Fan D. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer. 2008;123:372-379. [PMID: 18449891 DOI: 10.1002/ijc.23501] [Cited by in Crossref: 514] [Cited by in F6Publishing: 463] [Article Influence: 39.5] [Reference Citation Analysis]
169 Yamada Y, Enokida H, Kojima S, Kawakami K, Chiyomaru T, Tatarano S, Yoshino H, Kawahara K, Nishiyama K, Seki N. MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology. Cancer Sci. 2011;102:522-529. [PMID: 21166959 DOI: 10.1111/j.1349-7006.2010.01816.x] [Cited by in Crossref: 143] [Cited by in F6Publishing: 131] [Article Influence: 13.0] [Reference Citation Analysis]
170 Fabbri M, Paone A, Calore F, Galli R, Croce CM. A new role for microRNAs, as ligands of Toll-like receptors. RNA Biol. 2013;10:169-174. [PMID: 23296026 DOI: 10.4161/rna.23144] [Cited by in Crossref: 99] [Cited by in F6Publishing: 91] [Article Influence: 12.4] [Reference Citation Analysis]
171 Hufbauer M, Lazić D, Reinartz M, Akgül B, Pfister H, Weissenborn SJ. Skin tumor formation in human papillomavirus 8 transgenic mice is associated with a deregulation of oncogenic miRNAs and their tumor suppressive targets. Journal of Dermatological Science 2011;64:7-15. [DOI: 10.1016/j.jdermsci.2011.06.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
172 Rogler CE. MicroRNAs Make Inroads Into Liver Development. Gastroenterology 2009;136:770-2. [DOI: 10.1053/j.gastro.2009.01.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
173 Nigita G, Acunzo M, Romano G, Veneziano D, Laganà A, Vitiello M, Wernicke D, Ferro A, Croce CM. microRNA editing in seed region aligns with cellular changes in hypoxic conditions. Nucleic Acids Res 2016;44:6298-308. [PMID: 27298257 DOI: 10.1093/nar/gkw532] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
174 Calin GA, Croce CM. MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene 2006;25:6202-10. [DOI: 10.1038/sj.onc.1209910] [Cited by in Crossref: 182] [Cited by in F6Publishing: 161] [Article Influence: 12.1] [Reference Citation Analysis]
175 Li L, Hu X, Yang Z, Jia Z, Fang M, Zhang L, Zhou Y. Establishing reliable miRNA-cancer association network based on text-mining method. Comput Math Methods Med 2014;2014:746979. [PMID: 24895499 DOI: 10.1155/2014/746979] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
176 Paul S, Lakatos P, Hartmann A, Schneider-Stock R, Vera J. Identification of miRNA-mRNA Modules in Colorectal Cancer Using Rough Hypercuboid Based Supervised Clustering. Sci Rep 2017;7:42809. [PMID: 28220871 DOI: 10.1038/srep42809] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
177 Oak N, Ghosh R, Huang KL, Wheeler DA, Ding L, Plon SE. Framework for microRNA variant annotation and prioritization using human population and disease datasets. Hum Mutat 2019;40:73-89. [PMID: 30302893 DOI: 10.1002/humu.23668] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
178 Liu LZ, Li C, Chen Q, Jing Y, Carpenter R, Jiang Y, Kung HF, Lai L, Jiang BH. MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1α expression. PLoS One. 2011;6:e19139. [PMID: 21544242 DOI: 10.1371/journal.pone.0019139] [Cited by in Crossref: 285] [Cited by in F6Publishing: 281] [Article Influence: 28.5] [Reference Citation Analysis]
179 Wang R, Li M, Zhou S, Zeng D, Xu X, Xu R, Sun G. Effect of a single nucleotide polymorphism in miR-146a on COX-2 protein expression and lung function in smokers with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2015;10:463-73. [PMID: 25767384 DOI: 10.2147/COPD.S74345] [Cited by in Crossref: 4] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
180 Calin GA, Croce CM. Investigation of microRNA alterations in leukemias and lymphomas. Methods Enzymol 2007;427:193-213. [PMID: 17720486 DOI: 10.1016/S0076-6879(07)27011-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
181 Moss EG. Heterochronic Genes and the Nature of Developmental Time. Current Biology 2007;17:R425-34. [DOI: 10.1016/j.cub.2007.03.043] [Cited by in Crossref: 143] [Cited by in F6Publishing: 121] [Article Influence: 10.2] [Reference Citation Analysis]
182 Dalmay T. Short RNAs in environmental adaptation. Proc Biol Sci 2006;273:1579-85. [PMID: 16769627 DOI: 10.1098/rspb.2006.3516] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
183 Lafferty-whyte K, Cairney CJ, Jamieson NB, Oien KA, Keith WN. Pathway analysis of senescence-associated miRNA targets reveals common processes to different senescence induction mechanisms. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2009;1792:341-52. [DOI: 10.1016/j.bbadis.2009.02.003] [Cited by in Crossref: 84] [Cited by in F6Publishing: 79] [Article Influence: 7.0] [Reference Citation Analysis]
184 Le BH, Nguyen TT, Joo HN, Seo YJ. Large-Stokes-shift-based folded DNA probing systems targeting DNA and miRNA 21 with signal amplification. Bioorganic & Medicinal Chemistry 2018;26:4881-5. [DOI: 10.1016/j.bmc.2018.08.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
185 Patutina O, Mironova N, Ryabchikova E, Popova N, Nikolin V, Kaledin V, Vlassov V, Zenkova M. Inhibition of metastasis development by daily administration of ultralow doses of RNase A and DNase I. Biochimie. 2011;93:689-696. [PMID: 21194552 DOI: 10.1016/j.biochi.2010.12.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
186 Li Y, Zhu X, Gu J, Hu H, Dong D, Yao J, Lin C, Fei J. Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis. Hematology 2010;15:215-21. [PMID: 20670480 DOI: 10.1179/102453310X12647083620840] [Cited by in Crossref: 43] [Cited by in F6Publishing: 17] [Article Influence: 3.9] [Reference Citation Analysis]
187 Kang SM, Lee HJ. MicroRNAs in human lung cancer. Exp Biol Med (Maywood) 2014;239:1505-13. [PMID: 24872439 DOI: 10.1177/1535370214533887] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
188 Tong AW, Fulgham P, Jay C, Chen P, Khalil I, Liu S, Senzer N, Eklund AC, Han J, Nemunaitis J. MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther 2009;16:206-16. [PMID: 18949015 DOI: 10.1038/cgt.2008.77] [Cited by in Crossref: 193] [Cited by in F6Publishing: 178] [Article Influence: 14.8] [Reference Citation Analysis]
189 Tulay P, Sengupta SB. MicroRNA expression and its association with DNA repair in preimplantation embryos. J Reprod Dev 2016;62:225-34. [PMID: 26853522 DOI: 10.1262/jrd.2015-167] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
190 Salvi V, Gianello V, Tiberio L, Sozzani S, Bosisio D. Cytokine Targeting by miRNAs in Autoimmune Diseases. Front Immunol 2019;10:15. [PMID: 30761124 DOI: 10.3389/fimmu.2019.00015] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 16.5] [Reference Citation Analysis]
191 Rawoof A, Swaminathan G, Tiwari S, Nair RA, Dinesh Kumar L. LeukmiR: a database for miRNAs and their targets in acute lymphoblastic leukemia. Database (Oxford) 2020;2020:baz151. [PMID: 32128558 DOI: 10.1093/database/baz151] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
192 Calore F, Lovat F, Garofalo M. Non-coding RNAs and cancer. Int J Mol Sci 2013;14:17085-110. [PMID: 23965974 DOI: 10.3390/ijms140817085] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
193 Shiiba M, Shinozuka K, Saito K, Fushimi K, Kasamatsu A, Ogawara K, Uzawa K, Ito H, Takiguchi Y, Tanzawa H. MicroRNA-125b regulates proliferation and radioresistance of oral squamous cell carcinoma. Br J Cancer. 2013;108:1817-1821. [PMID: 23591197 DOI: 10.1038/bjc.2013.175] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 8.9] [Reference Citation Analysis]
194 Mizuguchi Y, Takizawa T, Uchida E. Host cellular microRNA involvement in the control of hepatitis B virus gene expression and replication. World J Hepatol. 2015;7:696-702. [PMID: 25866606 DOI: 10.4254/wjh.v7.i4.696] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
195 Jeong JH, Cheol Kang Y, Piao Y, Kang S, Pak YK. miR-24-mediated knockdown of H2AX damages mitochondria and the insulin signaling pathway. Exp Mol Med 2017;49:e313. [PMID: 28386126 DOI: 10.1038/emm.2016.174] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
196 Kubota S, Takigawa M. Role of CCN2/CTGF/Hcs24 in bone growth. Int Rev Cytol 2007;257:1-41. [PMID: 17280894 DOI: 10.1016/S0074-7696(07)57001-4] [Cited by in Crossref: 86] [Cited by in F6Publishing: 40] [Article Influence: 6.1] [Reference Citation Analysis]
197 Le BH, Seo YJ. Highly sensitive MicroRNA 146a detection using a gold nanoparticle-based CTG repeat probing system and isothermal amplification. Anal Chim Acta 2018;999:155-60. [PMID: 29254567 DOI: 10.1016/j.aca.2017.11.016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
198 Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem. 2009;284:3728-3738. [PMID: 19088079 DOI: 10.1074/jbc.] [Reference Citation Analysis]
199 Kondo T. Epigenetic alchemy for cell fate conversion. Curr Opin Genet Dev. 2006;16:502-507. [PMID: 16844365 DOI: 10.1016/j.gde.2006.07.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 2.2] [Reference Citation Analysis]
200 Manafi Shabestari R, Alikarami F, Bashash D, Paridar M, Safa M. Overexpression of MiR-138 Inhibits Cell Growth and Induces Caspase-mediated Apoptosis in Acute Promyelocytic Leukemia Cell Line. Int J Mol Cell Med 2018;7:24-31. [PMID: 30234070 DOI: 10.22088/IJMCM.BUMS.7.1.24] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
201 Calin GA, Garzon R, Cimmino A, Fabbri M, Croce CM. MicroRNAs and leukemias: How strong is the connection? Leukemia Research 2006;30:653-5. [DOI: 10.1016/j.leukres.2005.10.017] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
202 Enfield KS, Pikor LA, Martinez VD, Lam WL. Mechanistic Roles of Noncoding RNAs in Lung Cancer Biology and Their Clinical Implications. Genet Res Int 2012;2012:737416. [PMID: 22852089 DOI: 10.1155/2012/737416] [Cited by in Crossref: 23] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
203 Mironova N, Patutina O, Brenner E, Kurilshikov A, Vlassov V, Zenkova M. MicroRNA drop in the bloodstream and microRNA boost in the tumour caused by treatment with ribonuclease A leads to an attenuation of tumour malignancy. PLoS One 2013;8:e83482. [PMID: 24386211 DOI: 10.1371/journal.pone.0083482] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
204 Bandyopadhyay S, Mitra R, Maulik U, Zhang MQ. Development of the human cancer microRNA network. Silence. 2010;1:6. [PMID: 20226080 DOI: 10.1186/1758-907X-1-6] [Cited by in Crossref: 169] [Cited by in F6Publishing: 89] [Article Influence: 15.4] [Reference Citation Analysis]
205 Lakshmipathy U, Hart RP. Concise review: MicroRNA expression in multipotent mesenchymal stromal cells. Stem Cells 2008;26:356-63. [PMID: 17991914 DOI: 10.1634/stemcells.2007-0625] [Cited by in Crossref: 95] [Cited by in F6Publishing: 93] [Article Influence: 6.8] [Reference Citation Analysis]
206 Duk MA, Samsonova MG, Samsonov AM. Dynamics of miRNA driven feed-forward loop depends upon miRNA action mechanisms. BMC Genomics 2014;15 Suppl 12:S9. [PMID: 25563303 DOI: 10.1186/1471-2164-15-S12-S9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
207 Spizzo R, Rushworth D, Guerrero M, Calin GA. RNA inhibition, microRNAs, and new therapeutic agents for cancer treatment. Clin Lymphoma Myeloma 2009;9 Suppl 3:S313-8. [PMID: 19778859 DOI: 10.3816/CLM.2009.s.030] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
208 Cui R, Kim T, Fassan M, Meng W, Sun HL, Jeon YJ, Vicentini C, Tili E, Peng Y, Scarpa A, Liang G, Zhang YK, Chakravarti A, Croce CM. MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7. Oncotarget 2015;6:21802-15. [PMID: 26307684 DOI: 10.18632/oncotarget.5224] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 7.2] [Reference Citation Analysis]
209 Barmack NH, Pettorossi VE. Adaptive Balance in Posterior Cerebellum. Front Neurol 2021;12:635259. [PMID: 33767662 DOI: 10.3389/fneur.2021.635259] [Reference Citation Analysis]
210 Pivarcsi A, Ståhle M, Sonkoly E. Genetic polymorphisms altering microRNA activity in psoriasis - a key to solve the puzzle of missing heritability? Exp Dermatol 2014;23:620-4. [DOI: 10.1111/exd.12469] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
211 Conte I, Carrella S, Avellino R, Karali M, Marco-Ferreres R, Bovolenta P, Banfi S. miR-204 is required for lens and retinal development via Meis2 targeting. Proc Natl Acad Sci U S A 2010;107:15491-6. [PMID: 20713703 DOI: 10.1073/pnas.0914785107] [Cited by in Crossref: 103] [Cited by in F6Publishing: 97] [Article Influence: 9.4] [Reference Citation Analysis]
212 Paraboschi EM, Cardamone G, Rimoldi V, Duga S, Soldà G, Asselta R. miR-634 is a Pol III-dependent intronic microRNA regulating alternative-polyadenylated isoforms of its host gene PRKCA. Biochim Biophys Acta Gen Subj 2017;1861:1046-56. [PMID: 28212793 DOI: 10.1016/j.bbagen.2017.02.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
213 Yin Y, Yan ZP, Lu NN, Xu Q, He J, Qian X, Yu J, Guan X, Jiang BH, Liu LZ. Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1. Biochim Biophys Acta. 2013;1829:239-247. [PMID: 23201159 DOI: 10.1016/j.bbagrm.2012.11.006] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 6.3] [Reference Citation Analysis]
214 Fabbri M, Calore F, Paone A, Galli R, Calin GA. Epigenetic regulation of miRNAs in cancer. Adv Exp Med Biol 2013;754:137-48. [PMID: 22956499 DOI: 10.1007/978-1-4419-9967-2_6] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 6.8] [Reference Citation Analysis]
215 Pushparaj P, Aarthi J, Manikandan J, Kumar S. siRNA, miRNA, and shRNA: in vivo Applications. J Dent Res 2008;87:992-1003. [DOI: 10.1177/154405910808701109] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
216 Yu S, Li G. MicroRNA expression and function in cardiac ischemic injury. J Cardiovasc Transl Res 2010;3:241-5. [PMID: 20535240 DOI: 10.1007/s12265-010-9168-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
217 Zhu H, Wu H, Liu X, Evans BR, Medina DJ, Liu CG, Yang JM. Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol. 2008;76:582-588. [PMID: 18619946 DOI: 10.1016/j.bcp.2008.06.007] [Cited by in Crossref: 328] [Cited by in F6Publishing: 297] [Article Influence: 25.2] [Reference Citation Analysis]
218 Di Leva G, Calin GA, Croce CM. MicroRNAs: Fundamental facts and involvement in human diseases. Birth Defect Res C 2006;78:180-9. [DOI: 10.1002/bdrc.20073] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 3.9] [Reference Citation Analysis]
219 Shiiba M, Uzawa K, Tanzawa H. MicroRNAs in Head and Neck Squamous Cell Carcinoma (HNSCC) and Oral Squamous Cell Carcinoma (OSCC). Cancers (Basel) 2010;2:653-69. [PMID: 24281087 DOI: 10.3390/cancers2020653] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
220 Lotvall J, Valadi H. Cell to cell signalling via exosomes through esRNA. Cell Adh Migr 2007;1:156-8. [PMID: 19262134 DOI: 10.4161/cam.1.3.5114] [Cited by in Crossref: 167] [Cited by in F6Publishing: 172] [Article Influence: 11.9] [Reference Citation Analysis]
221 Castoldi M, Schmidt S, Benes V, Noerholm M, Kulozik AE, Hentze MW, Muckenthaler MU. A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). RNA. 2006;12:913-920. [PMID: 16540696 DOI: 10.1261/rna.2332406] [Cited by in Crossref: 307] [Cited by in F6Publishing: 279] [Article Influence: 20.5] [Reference Citation Analysis]
222 Wang M, Ye Y, Qian H, Song Z, Jia X, Zhang Z, Zhou J, Ni C. Common genetic variants in pre-microRNAs are associated with risk of coal workers' pneumoconiosis. J Hum Genet 2010;55:13-7. [DOI: 10.1038/jhg.2009.112] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]